日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Influence of low-intensity artificial light on the fatty acid profile of the biotechnologically important culinary mushroom Pleurotus eryngii in vitro

低强度人工光对具有重要生物技术应用价值的食用菌杏鲍菇体外脂肪酸组成的影响

Mykchaylova, Oksana; Besarab, Aleksander; Negriyko, Anatoliy; Lomberg, Margarita; Poyedinok, Natalia

Hemodialysis Vascular Access: A Historical Perspective on Access Promotion, Barriers, and Lessons for the Future

血液透析血管通路:通路推广、障碍及未来经验的历史视角

Besarab, Anatole; Frinak, Stanley; Margassery, Suresh; Wish, Jay B

Association of risk stratification score with dialysis vascular access stenosis

风险分层评分与透析血管通路狭窄的相关性

Kumbar, Lalathaksha; Astor, Brad C; Besarab, Anatole; Provenzano, Robert; Yee, Jerry

Development and validation of a risk score to prioritize patients for evaluation of access stenosis

开发和验证风险评分,以确定需要评估通路狭窄的患者优先级。

Astor, Brad C; Hirschman, Kim; Kennedy, John; Frinak, Stan; Besarab, Anatole

Roxadustat for CKD-related Anemia in Non-dialysis Patients

罗沙司他用于治疗非透析患者的慢性肾病相关性贫血

Coyne, Daniel W; Roger, Simon D; Shin, Sug Kyun; Kim, Sung Gyun; Cadena, Andres A; Moustafa, Moustafa A; Chan, Tak Mao; Besarab, Anatole; Chou, Willis; Bradley, Charles; Eyassu, Meraf; Leong, Robert; Lee, Tyson T; Saikali, Khalil G; Szczech, Lynda; Yu, Kin-Hung P

Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China

在中国开展的口服缺氧诱导因子脯氨酰羟化酶抑制剂FG-4592治疗贫血的II期临床研究

Chen, Nan; Qian, Jiaqi; Chen, Jianghua; Yu, Xueqing; Mei, Changlin; Hao, Chuanming; Jiang, Gengru; Lin, Hongli; Zhang, Xinzhou; Zuo, Li; He, Qiang; Fu, Ping; Li, Xuemei; Ni, Dalvin; Hemmerich, Stefan; Liu, Cameron; Szczech, Lynda; Besarab, Anatole; Neff, Thomas B; Peony Yu, Kin-Hung; Valone, Frank H

Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients

罗沙司他(FG-4592):用于治疗新发透析患者的贫血

Besarab, Anatole; Chernyavskaya, Elena; Motylev, Igor; Shutov, Evgeny; Kumbar, Lalathaksha M; Gurevich, Konstantin; Chan, Daniel Tak Mao; Leong, Robert; Poole, Lona; Zhong, Ming; Saikali, Khalil G; Franco, Marietta; Hemmerich, Stefan; Yu, Kin-Hung Peony; Neff, Thomas B

Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD

口服缺氧诱导因子脯氨酰羟化酶抑制剂罗沙司他(FG-4592)用于治疗慢性肾脏病患者的贫血

Provenzano, Robert; Besarab, Anatole; Sun, Chao H; Diamond, Susan A; Durham, John H; Cangiano, Jose L; Aiello, Joseph R; Novak, James E; Lee, Tyson; Leong, Robert; Roberts, Brian K; Saikali, Khalil G; Hemmerich, Stefan; Szczech, Lynda A; Yu, Kin-Hung Peony; Neff, Thomas B

Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients

通过透析液给予焦磷酸铁柠檬酸盐可减少促红细胞生成素的使用,并维持血液透析患者的血红蛋白水平。

Gupta, Ajay; Lin, Vivian; Guss, Carrie; Pratt, Raymond; Ikizler, T Alp; Besarab, Anatole

Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients

一项随机、安慰剂对照的罗沙司他(FG-4592)治疗非透析依赖性慢性肾脏病(NDD-CKD)患者贫血的剂量范围和药效学研究

Besarab, Anatole; Provenzano, Robert; Hertel, Joachim; Zabaneh, Raja; Klaus, Stephen J; Lee, Tyson; Leong, Robert; Hemmerich, Stefan; Yu, Kin-Hung Peony; Neff, Thomas B